chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Bedridden, Brain injury, Coagulation test, Dyspnoea, Feeling abnormal
Clinical narrative: The injury was catastrophic. It took away my ability to walk and I'm having breathing problems and lung issues - inability to walk, shortness of breath and significantly increased brain fog/damage. I am mostly bed ridden.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Gait inability, Injury, Lung disorder
Clinical narrative: The injury was catastrophic. It took away my ability to walk and I'm having breathing problems and lung issues - inability to walk, shortness of breath and significantly increased brain fog/damage. I am mostly bed ridden.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Fibrin D dimer increased, Palpitations, Pulmonary embolism
Clinical narrative: Patient has had palpitations since the day after getting her second booster dose. She has seen her primary care provider, and now cardiology, who sent her to the emergency department 5/10/22 for elevated d dimer. She was diagnosed with pulmonary emboli in the emergency department yesterday.
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: Vaccine vial MAY have not been diluted prior to use, as a result the patient may have received a higher than approved dose. Parent/Caregiver was notified, no concerns or adverse effects noted.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse reaction to the vaccine. The vaccine is administered, after the deadline of 1/April/2022. Vaccine is not expired.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Thrombectomy, Thrombosis
Clinical narrative: Developed blood clot in right leg.  Had three thrombectmomys to remove clots at a local HCF.  Clots came back after every operation.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia areata
Clinical narrative: Four large patches of hair have fallen out (Alopecia Areata) since date of third (booster) dose of Pfizer COVID-19 vaccine.  Hair loss discovered on 3/17/2022 and has worsened since that date.  Approximately 50% of my hair is now gone; have never had occurrence of AA in the past
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Pancreatitis
Clinical narrative: Pancreatitis requiring hospitalization
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Feeling abnormal, Oropharyngeal pain
Clinical narrative: Approximately 5 months after my booster shot (Dose 3) I contracted COVID-19 and have the following symptoms:  Sore throat, Body aches, Fatigue, Fever, Coughing, Brain Fog. I called for consultation and was recommended to take Chloraseptic - for sore throat  and Tylenol  - for body aches and fever. The medications did help improve my symptoms.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Approximately 5 months after my booster shot (Dose 3) I contracted COVID-19 and have the following symptoms:  Sore throat, Body aches, Fatigue, Fever, Coughing, Brain Fog. I called for consultation and was recommended to take Chloraseptic - for sore throat  and Tylenol  - for body aches and fever. The medications did help improve my symptoms.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram kidney abnormal, Lithotripsy, Nausea, Nephrolithiasis, Pain
Clinical narrative: On April 7, 2022 at 2:00AM I started having right sided pain. I went to the hospital and they said that I had a kidney stone. I was given fluids and medication to help with the pain. On April 9, 2022 I had similar pain and some nausea. I went back to the hospital and received some fluids and medicine again. I updated my doctor on what was going on and they said that I had some high elevation on my kidney test. I went to the ER and  more IV fluids was given. They did another CT Scan which showed the kidney stone still. They did the lithotripsy treatment on April 12, 2022.   I went back on April 19, 2022 and had the stent removed.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Renal function test abnormal, Stent removal
Clinical narrative: On April 7, 2022 at 2:00AM I started having right sided pain. I went to the hospital and they said that I had a kidney stone. I was given fluids and medication to help with the pain. On April 9, 2022 I had similar pain and some nausea. I went back to the hospital and received some fluids and medicine again. I updated my doctor on what was going on and they said that I had some high elevation on my kidney test. I went to the ER and  more IV fluids was given. They did another CT Scan which showed the kidney stone still. They did the lithotripsy treatment on April 12, 2022.   I went back on April 19, 2022 and had the stent removed.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Oropharyngeal pain, Pain in extremity, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: Next day arm hurts. On Saturday I felt congestive, Monday I had bad sore throat, I tested Positive Monday. Now I have COVID.
Age: 4.0
Sex: M
Vaccine: TD
Symptoms: No adverse event, Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: Patient given Tdap as fourth dose rather than Dtap..no adverse reactions on date of vaccine or day 2 via follow up call
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Pyrexia, Vomiting
Clinical narrative: Fever and aches on the evening of May 17 and nausea and vomit through the 18-21 of May 2021. Video appointment with my doctor on May 19 she then prescribed promethazine 25mg. It helped but it did make me very tired.
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Fully vaccinated, not boosted.  COVID breakthrough infection
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse reaction to the vaccine. The vaccine is administered, after the deadline of 1/April/2022. Vaccine is not expired.
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Vaccine vial MAY have not been diluted prior to use, as a result the patient may have received a higher than approved dose. Parent/Caregiver was notified, no concerns or adverse effects noted.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure inadequately controlled, Blood test, Coagulation time, Computerised tomogram, Therapeutic product ineffective
Clinical narrative: My blood pressure has been uncontrollable since getting this vaccine.  I had been off water pills for almost 4 years prior.  Since the vaccine I have been put back on water pills that did not lower my blood pressure; therefore, for the first time in my life I was put on blood pressure medication which did not regulate my blood pressure either.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: Wrong Covid vaccine given for patients age
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Swelling
Clinical narrative: Took bandage off after a week (Sun 5-8-22) started itching.  Next day (Mon 5-9-22) large 3" plus red area and itching.  Next day (Tues 5-10-22) large 3" plus area itching, and now SWOLLEN.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test normal, Fear, Feeling abnormal, Incomplete course of vaccination, Restlessness
Clinical narrative: Fell asleep normal time and woke up 1.5 hours later feeling like I was going to have a heart attack, felt like I was jumping out of my skin as if I wanted to jump off a building and that has never happened before. 3 days later it happened again to the point that I was afraid to fall asleep. When I spoke to my niece, her husband was having the same experience. Strange part is that after the vaccine I had the normal feels, but I started feeling unsettled, couldn't sit still and edgy. They put me on Zanex which I've never been on and at first they put me on Valum for emergency situations and I ended up taking 5 of them. I was afraid to get the second dose because I have never experienced any phycological things like that before. It was just very odd and wouldn't have reported it if I didn't have others that shared the similar experience.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Sleep disorder
Clinical narrative: Fell asleep normal time and woke up 1.5 hours later feeling like I was going to have a heart attack, felt like I was jumping out of my skin as if I wanted to jump off a building and that has never happened before. 3 days later it happened again to the point that I was afraid to fall asleep. When I spoke to my niece, her husband was having the same experience. Strange part is that after the vaccine I had the normal feels, but I started feeling unsettled, couldn't sit still and edgy. They put me on Zanex which I've never been on and at first they put me on Valum for emergency situations and I ended up taking 5 of them. I was afraid to get the second dose because I have never experienced any phycological things like that before. It was just very odd and wouldn't have reported it if I didn't have others that shared the similar experience.
Age: 90.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Fully vaccinated, and boosted twice.   COVID breakthrough infection
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Confusional state, Disturbance in attention, Panic attack, Postmenopausal haemorrhage
Clinical narrative: After the COVID vaccine on my 2nd dose, a couple weeks almost 3 weeks later, I noted that there was spotting. Vaginal spotting. I thought something was wrong. It was 1-3 days. Suddenly it just kept spotting. We did diagnostics, a pelvic vaginal ultrasound, pap smear, everything. They gave me a medication to stop the spotting - Aygestin. We did a vaginal ultrasound. After another week, I started having more flow. Like having a menstrual period which is not normal for me because I was menopausal 10 years ago. I went to the doctor and did this all again. She said it was really heavy. I bled and bled. Because of the medication, it didn?t work. Doctor scheduled me for DNC which was May 13, 2021. She said I would expect less bleeding in 1-2 weeks. Then June 2021, I was still spotting so I kept taking this medication and didn?t seem like it was helping. I bled a lot after the surgery. My whole pants were bleeding, pool of blood coming from vagina. I was put on iron supplement for a month and checked and rechecked. Early July 2021 I went to the ER and the whole wheelchair had so much blood. I had a panic attack and BP was 290 over 150. They put me on new medication ? Norvasc 5mg 1xday, so it hasn?t been bad. Went and got another pap smear and said it was not cancer. I?m not the same, I?m very active at work and I?ve lost my focus. Kind of like when you wake up and your back hurts, confused sometimes.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Smear cervix normal, Ultrasound scan vagina normal, Uterine dilation and curettage, Uterine leiomyoma, Vaginal haemorrhage
Clinical narrative: After the COVID vaccine on my 2nd dose, a couple weeks almost 3 weeks later, I noted that there was spotting. Vaginal spotting. I thought something was wrong. It was 1-3 days. Suddenly it just kept spotting. We did diagnostics, a pelvic vaginal ultrasound, pap smear, everything. They gave me a medication to stop the spotting - Aygestin. We did a vaginal ultrasound. After another week, I started having more flow. Like having a menstrual period which is not normal for me because I was menopausal 10 years ago. I went to the doctor and did this all again. She said it was really heavy. I bled and bled. Because of the medication, it didn?t work. Doctor scheduled me for DNC which was May 13, 2021. She said I would expect less bleeding in 1-2 weeks. Then June 2021, I was still spotting so I kept taking this medication and didn?t seem like it was helping. I bled a lot after the surgery. My whole pants were bleeding, pool of blood coming from vagina. I was put on iron supplement for a month and checked and rechecked. Early July 2021 I went to the ER and the whole wheelchair had so much blood. I had a panic attack and BP was 290 over 150. They put me on new medication ? Norvasc 5mg 1xday, so it hasn?t been bad. Went and got another pap smear and said it was not cancer. I?m not the same, I?m very active at work and I?ve lost my focus. Kind of like when you wake up and your back hurts, confused sometimes.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse reaction to the vaccine. The vaccine is administered, after the deadline of 1/April/2022. Vaccine is not expired.
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event, Product preparation issue
Clinical narrative: Vaccine vial MAY have not been diluted prior to use, as a result the patient may have received a higher than approved dose. Parent/Caregiver was notified, no concerns or adverse effects noted.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Fatigue, Feeling abnormal, Flatulence, Headache
Clinical narrative: I had a headache. I felt a little tired and run down. I also had abdominal pain, gas.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Pain as t injection site.  Swelling and redness, about 2 inches below injection site.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse reaction to the vaccine. The vaccine is administered, after the deadline of 1/April/2022. Vaccine is not expired.
Age: 10.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Anticoagulant therapy, Blood culture negative, Brain natriuretic peptide increased, Bundle branch block right, C-reactive protein increased
Clinical narrative: 2/9/22 11 y/o male who had COVID-19 in December, presented to the ER with 8 days of fever, pleuritic chest pain, headache, and malaise. Also 3 to 4 days of periorbital and lip swelling with a macular rash that resolved. Hypotensive 76/43, tachycardia at 126. MIS-C vs Kawasaki. Admitted to ICU. Resp: remained stable on RA. ID: He was given IVIG x1 on 2/10 and started on Methylprednisolone 1mg/kg BID. Blood & urine cultures were negative.  2/9 CXR - small left effusion, EKG w/right bundle branch block. Echo-good contractility, mitral valve insufficiency consistent w/myocarditis.  2/11 Inflammatory markers downtrending, transfer to floor. CV: BP's were stable and he did not require any pressors. He was started on Aspirin 81mg daily and Lovenox. Evidence of mild myocarditis with tachycardia and mildly elevated troponin, which downtrended prior to transfer to regular floor. Repeat Chest Xray on 2/11 showed small left basilar pleural effusion unchanged from previous examination. It also showed subsegmental consolidation left base, suspicious pneumonia, and WBC also increased to 26.52, patient was started on Ampicillin. Ampicillin later changed to PO Amoxicillin as PO tolerance improved and clinical impression improved. Methylprednisolone was also changed to PO Prednisone. Blood and urine cultures showed no growth after 5 and 2 days, respectively.   2/14 Repeat Echo showed trivial-to-small pericardial effusion located posteriorly behind the heart, with excellent biventricular function. Patient remained afebrile while on floor. Inflammatory markers and LFTs continued to downtrend. Electrolyte abnormalities resolved. Discharged 2/15/2022.
Age: 10.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Chest pain, Culture urine negative, Echocardiogram abnormal
Clinical narrative: 2/9/22 11 y/o male who had COVID-19 in December, presented to the ER with 8 days of fever, pleuritic chest pain, headache, and malaise. Also 3 to 4 days of periorbital and lip swelling with a macular rash that resolved. Hypotensive 76/43, tachycardia at 126. MIS-C vs Kawasaki. Admitted to ICU. Resp: remained stable on RA. ID: He was given IVIG x1 on 2/10 and started on Methylprednisolone 1mg/kg BID. Blood & urine cultures were negative.  2/9 CXR - small left effusion, EKG w/right bundle branch block. Echo-good contractility, mitral valve insufficiency consistent w/myocarditis.  2/11 Inflammatory markers downtrending, transfer to floor. CV: BP's were stable and he did not require any pressors. He was started on Aspirin 81mg daily and Lovenox. Evidence of mild myocarditis with tachycardia and mildly elevated troponin, which downtrended prior to transfer to regular floor. Repeat Chest Xray on 2/11 showed small left basilar pleural effusion unchanged from previous examination. It also showed subsegmental consolidation left base, suspicious pneumonia, and WBC also increased to 26.52, patient was started on Ampicillin. Ampicillin later changed to PO Amoxicillin as PO tolerance improved and clinical impression improved. Methylprednisolone was also changed to PO Prednisone. Blood and urine cultures showed no growth after 5 and 2 days, respectively.   2/14 Repeat Echo showed trivial-to-small pericardial effusion located posteriorly behind the heart, with excellent biventricular function. Patient remained afebrile while on floor. Inflammatory markers and LFTs continued to downtrend. Electrolyte abnormalities resolved. Discharged 2/15/2022.
Age: 10.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram abnormal, Electrolyte imbalance, Fibrin D dimer, Headache, Hypotension
Clinical narrative: 2/9/22 11 y/o male who had COVID-19 in December, presented to the ER with 8 days of fever, pleuritic chest pain, headache, and malaise. Also 3 to 4 days of periorbital and lip swelling with a macular rash that resolved. Hypotensive 76/43, tachycardia at 126. MIS-C vs Kawasaki. Admitted to ICU. Resp: remained stable on RA. ID: He was given IVIG x1 on 2/10 and started on Methylprednisolone 1mg/kg BID. Blood & urine cultures were negative.  2/9 CXR - small left effusion, EKG w/right bundle branch block. Echo-good contractility, mitral valve insufficiency consistent w/myocarditis.  2/11 Inflammatory markers downtrending, transfer to floor. CV: BP's were stable and he did not require any pressors. He was started on Aspirin 81mg daily and Lovenox. Evidence of mild myocarditis with tachycardia and mildly elevated troponin, which downtrended prior to transfer to regular floor. Repeat Chest Xray on 2/11 showed small left basilar pleural effusion unchanged from previous examination. It also showed subsegmental consolidation left base, suspicious pneumonia, and WBC also increased to 26.52, patient was started on Ampicillin. Ampicillin later changed to PO Amoxicillin as PO tolerance improved and clinical impression improved. Methylprednisolone was also changed to PO Prednisone. Blood and urine cultures showed no growth after 5 and 2 days, respectively.   2/14 Repeat Echo showed trivial-to-small pericardial effusion located posteriorly behind the heart, with excellent biventricular function. Patient remained afebrile while on floor. Inflammatory markers and LFTs continued to downtrend. Electrolyte abnormalities resolved. Discharged 2/15/2022.
Age: 10.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Immunoglobulin therapy, Inflammatory marker increased, Intensive care, Kawasaki's disease, Lip swelling
Clinical narrative: 2/9/22 11 y/o male who had COVID-19 in December, presented to the ER with 8 days of fever, pleuritic chest pain, headache, and malaise. Also 3 to 4 days of periorbital and lip swelling with a macular rash that resolved. Hypotensive 76/43, tachycardia at 126. MIS-C vs Kawasaki. Admitted to ICU. Resp: remained stable on RA. ID: He was given IVIG x1 on 2/10 and started on Methylprednisolone 1mg/kg BID. Blood & urine cultures were negative.  2/9 CXR - small left effusion, EKG w/right bundle branch block. Echo-good contractility, mitral valve insufficiency consistent w/myocarditis.  2/11 Inflammatory markers downtrending, transfer to floor. CV: BP's were stable and he did not require any pressors. He was started on Aspirin 81mg daily and Lovenox. Evidence of mild myocarditis with tachycardia and mildly elevated troponin, which downtrended prior to transfer to regular floor. Repeat Chest Xray on 2/11 showed small left basilar pleural effusion unchanged from previous examination. It also showed subsegmental consolidation left base, suspicious pneumonia, and WBC also increased to 26.52, patient was started on Ampicillin. Ampicillin later changed to PO Amoxicillin as PO tolerance improved and clinical impression improved. Methylprednisolone was also changed to PO Prednisone. Blood and urine cultures showed no growth after 5 and 2 days, respectively.   2/14 Repeat Echo showed trivial-to-small pericardial effusion located posteriorly behind the heart, with excellent biventricular function. Patient remained afebrile while on floor. Inflammatory markers and LFTs continued to downtrend. Electrolyte abnormalities resolved. Discharged 2/15/2022.
Age: 10.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Liver function test increased, Lung consolidation, Malaise, Mitral valve incompetence, Multisystem inflammatory syndrome in children
Clinical narrative: 2/9/22 11 y/o male who had COVID-19 in December, presented to the ER with 8 days of fever, pleuritic chest pain, headache, and malaise. Also 3 to 4 days of periorbital and lip swelling with a macular rash that resolved. Hypotensive 76/43, tachycardia at 126. MIS-C vs Kawasaki. Admitted to ICU. Resp: remained stable on RA. ID: He was given IVIG x1 on 2/10 and started on Methylprednisolone 1mg/kg BID. Blood & urine cultures were negative.  2/9 CXR - small left effusion, EKG w/right bundle branch block. Echo-good contractility, mitral valve insufficiency consistent w/myocarditis.  2/11 Inflammatory markers downtrending, transfer to floor. CV: BP's were stable and he did not require any pressors. He was started on Aspirin 81mg daily and Lovenox. Evidence of mild myocarditis with tachycardia and mildly elevated troponin, which downtrended prior to transfer to regular floor. Repeat Chest Xray on 2/11 showed small left basilar pleural effusion unchanged from previous examination. It also showed subsegmental consolidation left base, suspicious pneumonia, and WBC also increased to 26.52, patient was started on Ampicillin. Ampicillin later changed to PO Amoxicillin as PO tolerance improved and clinical impression improved. Methylprednisolone was also changed to PO Prednisone. Blood and urine cultures showed no growth after 5 and 2 days, respectively.   2/14 Repeat Echo showed trivial-to-small pericardial effusion located posteriorly behind the heart, with excellent biventricular function. Patient remained afebrile while on floor. Inflammatory markers and LFTs continued to downtrend. Electrolyte abnormalities resolved. Discharged 2/15/2022.
Age: 10.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Myocarditis, Pericardial effusion, Periorbital swelling, Pleural effusion, Pleuritic pain
Clinical narrative: 2/9/22 11 y/o male who had COVID-19 in December, presented to the ER with 8 days of fever, pleuritic chest pain, headache, and malaise. Also 3 to 4 days of periorbital and lip swelling with a macular rash that resolved. Hypotensive 76/43, tachycardia at 126. MIS-C vs Kawasaki. Admitted to ICU. Resp: remained stable on RA. ID: He was given IVIG x1 on 2/10 and started on Methylprednisolone 1mg/kg BID. Blood & urine cultures were negative.  2/9 CXR - small left effusion, EKG w/right bundle branch block. Echo-good contractility, mitral valve insufficiency consistent w/myocarditis.  2/11 Inflammatory markers downtrending, transfer to floor. CV: BP's were stable and he did not require any pressors. He was started on Aspirin 81mg daily and Lovenox. Evidence of mild myocarditis with tachycardia and mildly elevated troponin, which downtrended prior to transfer to regular floor. Repeat Chest Xray on 2/11 showed small left basilar pleural effusion unchanged from previous examination. It also showed subsegmental consolidation left base, suspicious pneumonia, and WBC also increased to 26.52, patient was started on Ampicillin. Ampicillin later changed to PO Amoxicillin as PO tolerance improved and clinical impression improved. Methylprednisolone was also changed to PO Prednisone. Blood and urine cultures showed no growth after 5 and 2 days, respectively.   2/14 Repeat Echo showed trivial-to-small pericardial effusion located posteriorly behind the heart, with excellent biventricular function. Patient remained afebrile while on floor. Inflammatory markers and LFTs continued to downtrend. Electrolyte abnormalities resolved. Discharged 2/15/2022.
Age: 10.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pneumonia, Pyrexia, Rash macular, Serum ferritin increased, Tachycardia
Clinical narrative: 2/9/22 11 y/o male who had COVID-19 in December, presented to the ER with 8 days of fever, pleuritic chest pain, headache, and malaise. Also 3 to 4 days of periorbital and lip swelling with a macular rash that resolved. Hypotensive 76/43, tachycardia at 126. MIS-C vs Kawasaki. Admitted to ICU. Resp: remained stable on RA. ID: He was given IVIG x1 on 2/10 and started on Methylprednisolone 1mg/kg BID. Blood & urine cultures were negative.  2/9 CXR - small left effusion, EKG w/right bundle branch block. Echo-good contractility, mitral valve insufficiency consistent w/myocarditis.  2/11 Inflammatory markers downtrending, transfer to floor. CV: BP's were stable and he did not require any pressors. He was started on Aspirin 81mg daily and Lovenox. Evidence of mild myocarditis with tachycardia and mildly elevated troponin, which downtrended prior to transfer to regular floor. Repeat Chest Xray on 2/11 showed small left basilar pleural effusion unchanged from previous examination. It also showed subsegmental consolidation left base, suspicious pneumonia, and WBC also increased to 26.52, patient was started on Ampicillin. Ampicillin later changed to PO Amoxicillin as PO tolerance improved and clinical impression improved. Methylprednisolone was also changed to PO Prednisone. Blood and urine cultures showed no growth after 5 and 2 days, respectively.   2/14 Repeat Echo showed trivial-to-small pericardial effusion located posteriorly behind the heart, with excellent biventricular function. Patient remained afebrile while on floor. Inflammatory markers and LFTs continued to downtrend. Electrolyte abnormalities resolved. Discharged 2/15/2022.
Age: 10.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Troponin increased, White blood cell count increased
Clinical narrative: 2/9/22 11 y/o male who had COVID-19 in December, presented to the ER with 8 days of fever, pleuritic chest pain, headache, and malaise. Also 3 to 4 days of periorbital and lip swelling with a macular rash that resolved. Hypotensive 76/43, tachycardia at 126. MIS-C vs Kawasaki. Admitted to ICU. Resp: remained stable on RA. ID: He was given IVIG x1 on 2/10 and started on Methylprednisolone 1mg/kg BID. Blood & urine cultures were negative.  2/9 CXR - small left effusion, EKG w/right bundle branch block. Echo-good contractility, mitral valve insufficiency consistent w/myocarditis.  2/11 Inflammatory markers downtrending, transfer to floor. CV: BP's were stable and he did not require any pressors. He was started on Aspirin 81mg daily and Lovenox. Evidence of mild myocarditis with tachycardia and mildly elevated troponin, which downtrended prior to transfer to regular floor. Repeat Chest Xray on 2/11 showed small left basilar pleural effusion unchanged from previous examination. It also showed subsegmental consolidation left base, suspicious pneumonia, and WBC also increased to 26.52, patient was started on Ampicillin. Ampicillin later changed to PO Amoxicillin as PO tolerance improved and clinical impression improved. Methylprednisolone was also changed to PO Prednisone. Blood and urine cultures showed no growth after 5 and 2 days, respectively.   2/14 Repeat Echo showed trivial-to-small pericardial effusion located posteriorly behind the heart, with excellent biventricular function. Patient remained afebrile while on floor. Inflammatory markers and LFTs continued to downtrend. Electrolyte abnormalities resolved. Discharged 2/15/2022.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain, COVID-19, Diet refusal, Hypophagia, Treatment noncompliance
Clinical narrative: COVID BREAKTHROUGH: over the last 5 days.  Because of the abdominal pain, the patient has felt that he cannot tolerate oral intake, and he has been avoiding food and his regular, maintenance medication.  Past medical history reports history of Cushing's disease, systemic lupus erythematosus, and major depression.  He has not been taking his maintenance therapy for at least 5 days according to his statement. The abdomen initially developed in the epigastric area, described as colicky pain, "coming and going", and because got better, at the last evening ER visit he decided to leave against medical advise from ER visit and go home. BOOSTER DOSE 11/30/2021.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vaccine breakthrough infection
Clinical narrative: COVID BREAKTHROUGH: over the last 5 days.  Because of the abdominal pain, the patient has felt that he cannot tolerate oral intake, and he has been avoiding food and his regular, maintenance medication.  Past medical history reports history of Cushing's disease, systemic lupus erythematosus, and major depression.  He has not been taking his maintenance therapy for at least 5 days according to his statement. The abdomen initially developed in the epigastric area, described as colicky pain, "coming and going", and because got better, at the last evening ER visit he decided to leave against medical advise from ER visit and go home. BOOSTER DOSE 11/30/2021.
Age: 7.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Arterial catheterisation, Bacterial test positive, Blood culture negative, Bronchial disorder
Clinical narrative: 7 yo girl, obese, presented with/4 day hx of fever nonresponsive to Tylenol (though significantly underdosed for weight), severe abdominal pain, vomiting, rash and conjunctivitis. 1/24 Admitted medical center, Differential included MISC vs vs septic shock secondary UTI. CRP 159, Procalcitonin 3.47, Ddimer3,618, Pro-BNP 2,376, PT 14.4. Tachypnic, hypotensive, elevated inflammatory markers, neg COVID and flu PCRs and pos COVID Abs. Urinalysis with +LE, bacteria, WBC. Blood & culture pending. Zosyn, vancomycin administered pending clinical course/culture results.  Increased tachypnea/fatigue 1/26 received IVIG overnight for possible MIS-C, echo with decrease in function, some PVCs noted overnight, concern for patient being at risk for need of escalation in cardiac support, iv linezolid and meropenem, decision to transfer to center with ECMO capabilities. Arterial line placed, pulse dose of Solumedrol given, turned over to transport team. Urine culture-probable contamination, blood culture-no growth at 4 days.
Age: 7.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: C-reactive protein increased, Cardiac dysfunction, Chest X-ray abnormal, Conjunctivitis, Culture urine positive
Clinical narrative: 7 yo girl, obese, presented with/4 day hx of fever nonresponsive to Tylenol (though significantly underdosed for weight), severe abdominal pain, vomiting, rash and conjunctivitis. 1/24 Admitted medical center, Differential included MISC vs vs septic shock secondary UTI. CRP 159, Procalcitonin 3.47, Ddimer3,618, Pro-BNP 2,376, PT 14.4. Tachypnic, hypotensive, elevated inflammatory markers, neg COVID and flu PCRs and pos COVID Abs. Urinalysis with +LE, bacteria, WBC. Blood & culture pending. Zosyn, vancomycin administered pending clinical course/culture results.  Increased tachypnea/fatigue 1/26 received IVIG overnight for possible MIS-C, echo with decrease in function, some PVCs noted overnight, concern for patient being at risk for need of escalation in cardiac support, iv linezolid and meropenem, decision to transfer to center with ECMO capabilities. Arterial line placed, pulse dose of Solumedrol given, turned over to transport team. Urine culture-probable contamination, blood culture-no growth at 4 days.
Age: 7.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Differential white blood cell count abnormal, Echocardiogram abnormal, Fatigue, Fibrin D dimer, Hypotension
Clinical narrative: 7 yo girl, obese, presented with/4 day hx of fever nonresponsive to Tylenol (though significantly underdosed for weight), severe abdominal pain, vomiting, rash and conjunctivitis. 1/24 Admitted medical center, Differential included MISC vs vs septic shock secondary UTI. CRP 159, Procalcitonin 3.47, Ddimer3,618, Pro-BNP 2,376, PT 14.4. Tachypnic, hypotensive, elevated inflammatory markers, neg COVID and flu PCRs and pos COVID Abs. Urinalysis with +LE, bacteria, WBC. Blood & culture pending. Zosyn, vancomycin administered pending clinical course/culture results.  Increased tachypnea/fatigue 1/26 received IVIG overnight for possible MIS-C, echo with decrease in function, some PVCs noted overnight, concern for patient being at risk for need of escalation in cardiac support, iv linezolid and meropenem, decision to transfer to center with ECMO capabilities. Arterial line placed, pulse dose of Solumedrol given, turned over to transport team. Urine culture-probable contamination, blood culture-no growth at 4 days.
Age: 7.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Immunoglobulin therapy, Infection, Inflammatory marker increased, Influenza virus test negative, Intensive care
Clinical narrative: 7 yo girl, obese, presented with/4 day hx of fever nonresponsive to Tylenol (though significantly underdosed for weight), severe abdominal pain, vomiting, rash and conjunctivitis. 1/24 Admitted medical center, Differential included MISC vs vs septic shock secondary UTI. CRP 159, Procalcitonin 3.47, Ddimer3,618, Pro-BNP 2,376, PT 14.4. Tachypnic, hypotensive, elevated inflammatory markers, neg COVID and flu PCRs and pos COVID Abs. Urinalysis with +LE, bacteria, WBC. Blood & culture pending. Zosyn, vancomycin administered pending clinical course/culture results.  Increased tachypnea/fatigue 1/26 received IVIG overnight for possible MIS-C, echo with decrease in function, some PVCs noted overnight, concern for patient being at risk for need of escalation in cardiac support, iv linezolid and meropenem, decision to transfer to center with ECMO capabilities. Arterial line placed, pulse dose of Solumedrol given, turned over to transport team. Urine culture-probable contamination, blood culture-no growth at 4 days.
Age: 7.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Kidney enlargement, Multisystem inflammatory syndrome in children, Pleural effusion, Procalcitonin, Prohormone brain natriuretic peptide increased
Clinical narrative: 7 yo girl, obese, presented with/4 day hx of fever nonresponsive to Tylenol (though significantly underdosed for weight), severe abdominal pain, vomiting, rash and conjunctivitis. 1/24 Admitted medical center, Differential included MISC vs vs septic shock secondary UTI. CRP 159, Procalcitonin 3.47, Ddimer3,618, Pro-BNP 2,376, PT 14.4. Tachypnic, hypotensive, elevated inflammatory markers, neg COVID and flu PCRs and pos COVID Abs. Urinalysis with +LE, bacteria, WBC. Blood & culture pending. Zosyn, vancomycin administered pending clinical course/culture results.  Increased tachypnea/fatigue 1/26 received IVIG overnight for possible MIS-C, echo with decrease in function, some PVCs noted overnight, concern for patient being at risk for need of escalation in cardiac support, iv linezolid and meropenem, decision to transfer to center with ECMO capabilities. Arterial line placed, pulse dose of Solumedrol given, turned over to transport team. Urine culture-probable contamination, blood culture-no growth at 4 days.
Age: 7.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Prothrombin time prolonged, Pyelonephritis, Pyrexia, Rash, SARS-CoV-2 antibody test positive
Clinical narrative: 7 yo girl, obese, presented with/4 day hx of fever nonresponsive to Tylenol (though significantly underdosed for weight), severe abdominal pain, vomiting, rash and conjunctivitis. 1/24 Admitted medical center, Differential included MISC vs vs septic shock secondary UTI. CRP 159, Procalcitonin 3.47, Ddimer3,618, Pro-BNP 2,376, PT 14.4. Tachypnic, hypotensive, elevated inflammatory markers, neg COVID and flu PCRs and pos COVID Abs. Urinalysis with +LE, bacteria, WBC. Blood & culture pending. Zosyn, vancomycin administered pending clinical course/culture results.  Increased tachypnea/fatigue 1/26 received IVIG overnight for possible MIS-C, echo with decrease in function, some PVCs noted overnight, concern for patient being at risk for need of escalation in cardiac support, iv linezolid and meropenem, decision to transfer to center with ECMO capabilities. Arterial line placed, pulse dose of Solumedrol given, turned over to transport team. Urine culture-probable contamination, blood culture-no growth at 4 days.
Age: 7.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test negative, Septic shock, Tachypnoea, Total lung capacity decreased, Ultrasound kidney abnormal
Clinical narrative: 7 yo girl, obese, presented with/4 day hx of fever nonresponsive to Tylenol (though significantly underdosed for weight), severe abdominal pain, vomiting, rash and conjunctivitis. 1/24 Admitted medical center, Differential included MISC vs vs septic shock secondary UTI. CRP 159, Procalcitonin 3.47, Ddimer3,618, Pro-BNP 2,376, PT 14.4. Tachypnic, hypotensive, elevated inflammatory markers, neg COVID and flu PCRs and pos COVID Abs. Urinalysis with +LE, bacteria, WBC. Blood & culture pending. Zosyn, vancomycin administered pending clinical course/culture results.  Increased tachypnea/fatigue 1/26 received IVIG overnight for possible MIS-C, echo with decrease in function, some PVCs noted overnight, concern for patient being at risk for need of escalation in cardiac support, iv linezolid and meropenem, decision to transfer to center with ECMO capabilities. Arterial line placed, pulse dose of Solumedrol given, turned over to transport team. Urine culture-probable contamination, blood culture-no growth at 4 days.
Age: 7.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urinary tract infection, Urine analysis abnormal, Urine leukocyte esterase positive, Ventricular extrasystoles, Vomiting
Clinical narrative: 7 yo girl, obese, presented with/4 day hx of fever nonresponsive to Tylenol (though significantly underdosed for weight), severe abdominal pain, vomiting, rash and conjunctivitis. 1/24 Admitted medical center, Differential included MISC vs vs septic shock secondary UTI. CRP 159, Procalcitonin 3.47, Ddimer3,618, Pro-BNP 2,376, PT 14.4. Tachypnic, hypotensive, elevated inflammatory markers, neg COVID and flu PCRs and pos COVID Abs. Urinalysis with +LE, bacteria, WBC. Blood & culture pending. Zosyn, vancomycin administered pending clinical course/culture results.  Increased tachypnea/fatigue 1/26 received IVIG overnight for possible MIS-C, echo with decrease in function, some PVCs noted overnight, concern for patient being at risk for need of escalation in cardiac support, iv linezolid and meropenem, decision to transfer to center with ECMO capabilities. Arterial line placed, pulse dose of Solumedrol given, turned over to transport team. Urine culture-probable contamination, blood culture-no growth at 4 days.
Age: 7.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: White blood cells urine positive
Clinical narrative: 7 yo girl, obese, presented with/4 day hx of fever nonresponsive to Tylenol (though significantly underdosed for weight), severe abdominal pain, vomiting, rash and conjunctivitis. 1/24 Admitted medical center, Differential included MISC vs vs septic shock secondary UTI. CRP 159, Procalcitonin 3.47, Ddimer3,618, Pro-BNP 2,376, PT 14.4. Tachypnic, hypotensive, elevated inflammatory markers, neg COVID and flu PCRs and pos COVID Abs. Urinalysis with +LE, bacteria, WBC. Blood & culture pending. Zosyn, vancomycin administered pending clinical course/culture results.  Increased tachypnea/fatigue 1/26 received IVIG overnight for possible MIS-C, echo with decrease in function, some PVCs noted overnight, concern for patient being at risk for need of escalation in cardiac support, iv linezolid and meropenem, decision to transfer to center with ECMO capabilities. Arterial line placed, pulse dose of Solumedrol given, turned over to transport team. Urine culture-probable contamination, blood culture-no growth at 4 days.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Wrong dose given for patients age
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, COVID-19, Flank pain, Musculoskeletal discomfort, Pain
Clinical narrative: Six to eight weeks after the vaccine it felt like I had dislocated my shoulder. The pain radiated down my whole left side lasting for twelve hours. I had a fever that lasted for about 20 to 30 minutes once it broke I felt like I was back to normal. On May 5, 2022 I tested positive for COVID, I do not feel bad at all.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Six to eight weeks after the vaccine it felt like I had dislocated my shoulder. The pain radiated down my whole left side lasting for twelve hours. I had a fever that lasted for about 20 to 30 minutes once it broke I felt like I was back to normal. On May 5, 2022 I tested positive for COVID, I do not feel bad at all.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: NUMBNESS AND TINGLING IN FACE STARTED WITHIN 24 HOURS OF VACCINATION AND LASTED APPROXIMATELY 14 DAYS
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Wrong dose of covid vaccine given for patients age
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Blood creatine phosphokinase normal, Blood fibrinogen increased, Blood lactate dehydrogenase normal, Brain natriuretic peptide increased, C-reactive protein increased
Clinical narrative: On 01/08/22, she developed a cough and fever then subsequently tested positive for COVID-19 on 01/10. She started improving and felt better until 01/13 at which time she developed high fevers 102-103F with Tmax 106F, nausea with multiple episodes of vomiting, diffuse myalgias with hand and foot edema, and malaise. Admitted on 01/16/22 for MIS-C, received 1 dose of IVIg on 01/17, and was discharged on Tuesday 01/18 on prednisone 40 mg PO and aspirin 81 mg. Readmitted on after resurgence of fever/102F, nausea, myalgias, and a mild headache. Mother noted she has been very fatigued. Likely secondary to refractory MIS-C, cannot rule out other source of infection. No fever since admission. Labs done on admission reassuring; showed continued downtrend of inflammatory markers. 1/20 Labs: WBC 12.8 (unchanged from 1/19) CK WLN, LD WLN, fibrinogen 618 (down from 782 on 1/18), D-dimer 2.38 WLN (slight increase from 1.69 on 1/16), CRP 30 (down from 56.1 on 1/19). Naproxen 375mg BID AMD Pepcid started on 1/21. Discharged 1/22 on prednisone 40 mg daily and ASA 81 mg ,
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Cough, Fatigue
Clinical narrative: On 01/08/22, she developed a cough and fever then subsequently tested positive for COVID-19 on 01/10. She started improving and felt better until 01/13 at which time she developed high fevers 102-103F with Tmax 106F, nausea with multiple episodes of vomiting, diffuse myalgias with hand and foot edema, and malaise. Admitted on 01/16/22 for MIS-C, received 1 dose of IVIg on 01/17, and was discharged on Tuesday 01/18 on prednisone 40 mg PO and aspirin 81 mg. Readmitted on after resurgence of fever/102F, nausea, myalgias, and a mild headache. Mother noted she has been very fatigued. Likely secondary to refractory MIS-C, cannot rule out other source of infection. No fever since admission. Labs done on admission reassuring; showed continued downtrend of inflammatory markers. 1/20 Labs: WBC 12.8 (unchanged from 1/19) CK WLN, LD WLN, fibrinogen 618 (down from 782 on 1/18), D-dimer 2.38 WLN (slight increase from 1.69 on 1/16), CRP 30 (down from 56.1 on 1/19). Naproxen 375mg BID AMD Pepcid started on 1/21. Discharged 1/22 on prednisone 40 mg daily and ASA 81 mg ,
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Fibrin D dimer normal, Headache, Immunoglobulin therapy, Inflammatory marker test, Malaise
Clinical narrative: On 01/08/22, she developed a cough and fever then subsequently tested positive for COVID-19 on 01/10. She started improving and felt better until 01/13 at which time she developed high fevers 102-103F with Tmax 106F, nausea with multiple episodes of vomiting, diffuse myalgias with hand and foot edema, and malaise. Admitted on 01/16/22 for MIS-C, received 1 dose of IVIg on 01/17, and was discharged on Tuesday 01/18 on prednisone 40 mg PO and aspirin 81 mg. Readmitted on after resurgence of fever/102F, nausea, myalgias, and a mild headache. Mother noted she has been very fatigued. Likely secondary to refractory MIS-C, cannot rule out other source of infection. No fever since admission. Labs done on admission reassuring; showed continued downtrend of inflammatory markers. 1/20 Labs: WBC 12.8 (unchanged from 1/19) CK WLN, LD WLN, fibrinogen 618 (down from 782 on 1/18), D-dimer 2.38 WLN (slight increase from 1.69 on 1/16), CRP 30 (down from 56.1 on 1/19). Naproxen 375mg BID AMD Pepcid started on 1/21. Discharged 1/22 on prednisone 40 mg daily and ASA 81 mg ,
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Multisystem inflammatory syndrome in children, Myalgia, Nausea, Oedema peripheral, Procalcitonin
Clinical narrative: On 01/08/22, she developed a cough and fever then subsequently tested positive for COVID-19 on 01/10. She started improving and felt better until 01/13 at which time she developed high fevers 102-103F with Tmax 106F, nausea with multiple episodes of vomiting, diffuse myalgias with hand and foot edema, and malaise. Admitted on 01/16/22 for MIS-C, received 1 dose of IVIg on 01/17, and was discharged on Tuesday 01/18 on prednisone 40 mg PO and aspirin 81 mg. Readmitted on after resurgence of fever/102F, nausea, myalgias, and a mild headache. Mother noted she has been very fatigued. Likely secondary to refractory MIS-C, cannot rule out other source of infection. No fever since admission. Labs done on admission reassuring; showed continued downtrend of inflammatory markers. 1/20 Labs: WBC 12.8 (unchanged from 1/19) CK WLN, LD WLN, fibrinogen 618 (down from 782 on 1/18), D-dimer 2.38 WLN (slight increase from 1.69 on 1/16), CRP 30 (down from 56.1 on 1/19). Naproxen 375mg BID AMD Pepcid started on 1/21. Discharged 1/22 on prednisone 40 mg daily and ASA 81 mg ,
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Serum ferritin increased, Urine analysis normal, Vomiting
Clinical narrative: On 01/08/22, she developed a cough and fever then subsequently tested positive for COVID-19 on 01/10. She started improving and felt better until 01/13 at which time she developed high fevers 102-103F with Tmax 106F, nausea with multiple episodes of vomiting, diffuse myalgias with hand and foot edema, and malaise. Admitted on 01/16/22 for MIS-C, received 1 dose of IVIg on 01/17, and was discharged on Tuesday 01/18 on prednisone 40 mg PO and aspirin 81 mg. Readmitted on after resurgence of fever/102F, nausea, myalgias, and a mild headache. Mother noted she has been very fatigued. Likely secondary to refractory MIS-C, cannot rule out other source of infection. No fever since admission. Labs done on admission reassuring; showed continued downtrend of inflammatory markers. 1/20 Labs: WBC 12.8 (unchanged from 1/19) CK WLN, LD WLN, fibrinogen 618 (down from 782 on 1/18), D-dimer 2.38 WLN (slight increase from 1.69 on 1/16), CRP 30 (down from 56.1 on 1/19). Naproxen 375mg BID AMD Pepcid started on 1/21. Discharged 1/22 on prednisone 40 mg daily and ASA 81 mg ,